Sign in
4

Changes in Ownership

Cartesian Therapeutics, Inc. Filed Acc 0001453687-24-000057

Options or other derivatives

  • Chief Technology Officer acquired 7,269.97 shares (option exercise)
  • Chief Technology Officer acquired 242,328 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Kurtoglu Metin · Chief Technology Officer

Table II: Derivative

6 lines
Date Transaction Shares Owned after D/I
2024-04-08 Exercise or conversion : show line 1 in the form Stock Option (Right to Buy) −6,414.68 0 D
2024-04-08 Exercise or conversion : show line 2 in the form Stock Option (Right to Buy) +213,820 213,820 D
2024-04-08 Exercise or conversion : show line 3 in the form Stock Option (Right to Buy) −427.65 0 D
2024-04-08 Exercise or conversion : show line 4 in the form Stock Option (Right to Buy) +14,254 14,254 D
2024-04-08 Exercise or conversion : show line 5 in the form Stock Option (Right to Buy) −427.65 0 D
2024-04-08 Exercise or conversion : show line 6 in the form Stock Option (Right to Buy) +14,254 14,254 D
Loading xslF345X05/wk-form4_1712799040.xml…